Wuhan Tianyuan Group (301127.SZ) subsidiary plans to acquire 100% equity of Jiangsu Kairun Hydrogen Energy to optimize its layout.
Wuhan Tianyuan (301127.SZ) announced that its wholly-owned subsidiary Jiangsu Green East Hydrogen Energy Technology Co., Ltd. ("Jiangsu Hydrogen Technology") intends to acquire 100% of the equity of Jiangsu Kairun Hydrogen Energy Co., Ltd. ("Jiangsu Kairun Hydrogen"), a holding subsidiary of its controlled subsidiary Wuhan Tianyuan Energy Co., Ltd. ("Tianyuan Energy"), for a consideration of 30.49 million yuan. This transaction involves the purchase of assets from the company's wholly-owned subsidiary by the company's controlled subsidiary, which is beneficial for the overall planning and layout optimization of Jiangsu Hydrogen Technology.
Wuhan Tianyuan Group (301127.SZ) announced that its fully-owned subsidiary, Jiangsu Green East Hydrogen Energy Technology Co., Ltd. ("Jiangsu Hydrogen Technology"), plans to acquire 100% equity of Jiangsu Kairun Hydrogen Energy Co., Ltd. ("Jiangsu Kairun Hydrogen") held by the company's controlling subsidiary, Wuhan Tianyuan Group Energy Co., Ltd. ("Tianyuan Energy") for a consideration of 30.49 million yuan. This transaction involves the company's fully-owned subsidiary purchasing assets from the company's controlling subsidiary, which is beneficial for the overall planning and layout optimization of Jiangsu Hydrogen Technology.
Related Articles

CHINA LESSO (02128) and Guangdong Liansu Electric have signed a parts supply agreement.

Jiangsu Hengrui Pharmaceuticals (01276): SHR-2906 Injection Obtains Drug Clinical Trial Approval Letter.

Jiangsu Hengrui Pharmaceuticals (01276): SHR-9539 injection, HRS-3738 tablets received the approval notice for drug clinical trials.
CHINA LESSO (02128) and Guangdong Liansu Electric have signed a parts supply agreement.

Jiangsu Hengrui Pharmaceuticals (01276): SHR-2906 Injection Obtains Drug Clinical Trial Approval Letter.

Jiangsu Hengrui Pharmaceuticals (01276): SHR-9539 injection, HRS-3738 tablets received the approval notice for drug clinical trials.






